Search research articles
Contact Us
Filters
Showing results (861-870 of 1,362) with videos related to
Page
of 137
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 24, 2005
Enhanced programmed cell death of iron-deficient erythrocytes
Daniela S Kempe, Philipp A Lang, Christophe Duranton, et al.
Biochemical Pharmacology
|
December 1, 1990
Immunochemical detection of human liver cytochrome P450 forms related to phenobarbital-inducible forms in the mouse
H Raunio, J Valtonen, P Honkakoski, et al.
Development (Cambridge, England)
|
May 24, 2000
FGF10 is an inducer and Pax6 a competence factor for lacrimal gland development
H P Makarenkova, M Ito, V Govindarajan, et al.
Biochemical Pharmacology
|
October 15, 1988
Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse
H Raunio, T Syngelmä, M Pasanen, et al.
International Journal of Oncology
|
January 23, 2013
EGCG inhibits recepteur d'origine nantais expression by suppressing Egr-1 in gastric cancer cells
Jung Sun Park, Pham Ngoc Khoi, Young Eun Joo, et al.
Journal of Neurophysiology
|
September 3, 2020
Baroreflex function in Parkinson's disease: insights from the modified-Oxford technique
Jeann L Sabino-Carvalho, Roberta A Cartafina, Gabriel M Guimarães, et al.
The Journal of Biological Chemistry
|
January 19, 2025
An engineered palivizumab IgG2 subclass for synthetic gp130 and fas-mediated signaling
Christoph Wittich, Julia Ettich, Marcel Hertell, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|
December 14, 2011
Tissue-engineered provisional matrix as a novel approach to enhance diabetic wound healing
Swathi Balaji, Sachin S Vaikunth, Stephanie A Lang, et al.
BMC Cancer
|
July 25, 2008
ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo
Christian Moser, Sven A Lang, Akira Mori, et al.
Annals of Hematology
|
September 8, 2010
Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis
W Lamm, W Willenbacher, A Lang, et al.
Page
of 137
Search research articles
Search
Showing results (861-870 of 1,362) with videos related to
Sort By:
Page
of 137
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 24, 2005
Enhanced programmed cell death of iron-deficient erythrocytes
Daniela S Kempe, Philipp A Lang, Christophe Duranton, et al.
Biochemical Pharmacology
|
December 1, 1990
Immunochemical detection of human liver cytochrome P450 forms related to phenobarbital-inducible forms in the mouse
H Raunio, J Valtonen, P Honkakoski, et al.
Development (Cambridge, England)
|
May 24, 2000
FGF10 is an inducer and Pax6 a competence factor for lacrimal gland development
H P Makarenkova, M Ito, V Govindarajan, et al.
Biochemical Pharmacology
|
October 15, 1988
Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse
H Raunio, T Syngelmä, M Pasanen, et al.
International Journal of Oncology
|
January 23, 2013
EGCG inhibits recepteur d'origine nantais expression by suppressing Egr-1 in gastric cancer cells
Jung Sun Park, Pham Ngoc Khoi, Young Eun Joo, et al.
Journal of Neurophysiology
|
September 3, 2020
Baroreflex function in Parkinson's disease: insights from the modified-Oxford technique
Jeann L Sabino-Carvalho, Roberta A Cartafina, Gabriel M Guimarães, et al.
The Journal of Biological Chemistry
|
January 19, 2025
An engineered palivizumab IgG2 subclass for synthetic gp130 and fas-mediated signaling
Christoph Wittich, Julia Ettich, Marcel Hertell, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|
December 14, 2011
Tissue-engineered provisional matrix as a novel approach to enhance diabetic wound healing
Swathi Balaji, Sachin S Vaikunth, Stephanie A Lang, et al.
BMC Cancer
|
July 25, 2008
ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo
Christian Moser, Sven A Lang, Akira Mori, et al.
Annals of Hematology
|
September 8, 2010
Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis
W Lamm, W Willenbacher, A Lang, et al.
Page
of 137